Home > News > Top Stories > Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System

Future of Healthcare

Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System

Bumrungrad International

Lunit, a leading medical AI provider, announced that it has signed a contract with FujiFilm Thailand and Microsoft to supply AI cancer screening products to Bumrungrad International Hospital, located in Bangkok, Thailand. Under the agreement, Lunit INSIGHT CXR, a CE-marked chest x-ray analysis AI software, and Lunit INSIGHT MMG, an FDA-cleared AI solution for detecting breast cancer in early stages, are deployed in Bumrungrad hospital.

Lunit and FujiFilm Thailand supply AI solutions to Bumrungrad hospital using Microsoft Azure, a global cloud computing platform. Lunit and Microsoft have been partnering to deliver state-of-the-art medical AI technology to more diagnostic practices globally. Based on previous collaboration experiences, Microsoft Azure will enhance the operation of Lunit's software at Bumrungrad hospital.

Bumrungrad, the only Thai hospital named as 'World's Best Hospitals 2022' by Newsweek, is one of the largest private hospitals in Southeast Asia, with 580 beds and treating 1.1 million patients annually from more than 190 different countries.

Currently, the hospital is actively using Lunit AI solutions in its check-ups, intensive care units, emergency rooms, and more. Lunit INSIGHT CXR and Lunit INSIGHT MMG analyze more than 100,000 medical images that are annually taken in the hospital. Through AI, Bumrungrad aims to provide better services by timely detection of chest abnormalities and breast cancer. Lunit plans to further support Bumrungrad to drive groundbreaking medical innovation across Southeast Asia.

"Bumrungrad International Hospital, widely recognized as an international medical destination, has been creating innovative clinical experiences that can serve patients' needs and solve pain points for nearly four decades. We are delighted to introduce our AI solutions to Bumrungrad, which strives to ensure a healthier life for patients. We also expect the partnership with Microsoft, a leading cloud service provider, will expand the reach of Lunit INSIGHT CXR and Lunit INSIGHT MMG into further sites across the world so that our INSIGHT suite supports more hospitals detecting critical findings."

Brandon Suh, CEO of Lunit

"Medical imaging has been another area of healthcare identified as 'highly potential' for artificial intelligence (AI) applications. AI would be a support tool for human decision-making, providing a second opinion for doctors' consideration during the diagnostic process. An additional benefit we anticipate for the AI system is its ability to speed up the learning curve for junior doctors with less experience in reading images," said Dr. Teeradache Viangteeravat, Director of Research and Development at Bumrungrad International Hospital. "Lunit is a world leader in this space and can provide a suite of integrated AI solutions, which support our strategic objectives. We are proud to be working with Lunit to implement world-class medical AI imaging solutions to continue delivering high-quality support that fits our patients' and clinicians' demands."

Spotlight

More featured news

Spotlight

Related News

Healthcare Analytics

Hartford HealthCare and Walgreens partner to provide health clinics that improve access to care

PR Newswire | October 26, 2023

Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England. Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in. The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers. Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services. said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations. [Source:PR Newswire] "Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy." Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.

Read More

Healthcare Analytics

GE HealthCare Releases Sustainability Report, Shares Future Goals

GE HealthCare | September 25, 2023

First Sustainability Report since January 2023 showcases the company’s commitment to creating a world with no healthcare limits Report shows reduced operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 Strong leadership focus on sustainability efforts and ESG with a cross-functional ESP GE HealthCare has released its inaugural Sustainability Report, marking its commitment to environmental, social, and governance (ESG) practices since becoming an independent company in January 2023. The report highlights the reduction of operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 and outlines the company's dedication to ESG principles and sustainability. GE HealthCare recognizes the importance of sustainability and corporate responsibility in the healthcare industry. The report reflects the company's dedication to creating a world where healthcare knows no limits and its commitment to environmental and social impact. ESG Program Leader at GE HealthCare, Kelvin Sanborn, stated, GE HealthCare recognizes the global significance of fulfilling our purpose and delivering on our objectives and is pleased to have reduced our operational GHG emissions by 27% versus our 2019 baseline. With our broad ESG strategy and priorities in mind, we are carrying out a climate risk assessment that will inform our climate transition plan, and developing a net zero roadmap for Scope 1, 2, and 3 GHG emissions. [Source: Business Wire] Key Highlights from the Company's Inaugural Sustainability Report: Environmental Impact Since 2019, reduced GHG emissions by 27% with goals of 50% reduction by 2030 and net zero by 2050 Registered with Science Based Targets Initiative Committed to decarbonizing the healthcare sector Social Impact Established cultural operating principles Planned GE Healthcare Foundation for philanthropy Appointed chief diversity, equity, and inclusion officer Governance and Accountability Strong corporate governance as a stand-alone public company Relaunched Code of Conduct with high employee engagement Joined UN Global Compact to support sustainable development goals GE HealthCare conducted an ESG materiality assessment, defining five key focus areas for its sustainability strategy. These include expanding healthcare access, fostering diversity and inclusion, reducing greenhouse gas emissions, promoting the circular economy, and enhancing patient data cybersecurity. The report outlines the company's long-term ESG objectives and progress toward previous goals. It is preparing to release an updated task force on climate-related financial disclosures (TCFD) report once its climate risk assessment is finalized. Furthermore, the company has scheduled a materiality assessment update for 2024. In parallel, GE HealthCare is exploring the expansion of Reporting Standards for its ESG disclosures and evaluating how its objectives align with the United Nations Sustainable Development Goals (UN SDGs). After conducting an ESG materiality assessment before its spin-off, the company has pinpointed five vital areas for its sustainability strategy. These priorities, underscored by the company's core innovation, product quality, and integrity principles, encompass the following: Expanding global healthcare access by ensuring underserved populations have better healthcare opportunities; promoting a culture of inclusion and diversity; mitigating its climate impact through concerted efforts; facilitating equipment and prioritizing patient data security and cybersecurity by adhering to standardized data privacy and security practices based on global regulations such as the EU GDPR.

Read More

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Read More

Healthcare Analytics

Hartford HealthCare and Walgreens partner to provide health clinics that improve access to care

PR Newswire | October 26, 2023

Walgreens and Hartford HealthCare will add health clinics to select Walgreens locations in Connecticut, advancing a unique retail health model based on convenience, access to care, affordability and health equity. This is Walgreens first retail clinic collaboration with a health system in New England. Under a clinical collaboration agreement, five clinics operated by Hartford HealthCare medical providers will be added to Walgreens locations, including 340 Flanders Road, in East Lyme (at Flanders Four Corners); 2 Shaker Road, in Enfield; 235 Main Street, in Norwalk; and 203 Kennedy Drive, in Putnam. One additional location will be announced in the coming months. Hartford HealthCare at Walgreens clinics are scheduled to open within a year and will offer primary care, screenings, vaccinations, confidential telehealth services and more, seven days per week by appointment or walk-in. The collaboration is based on the organizations' shared vision to improve access to care, reduce healthcare costs and offer convenient access to essential primary care and pharmacy services. The locations will offer consumers a convenient destination to access both Walgreens experience in community retail health and pharmacy operations and Hartford HealthCare's expertise in delivering patient care, employing highly qualified medical professionals, and operating health centers. Hartford HealthCare at Walgreens will combine in-person care from a medical professional and, when needed, confidential in-store virtual care. For ease of access, an employee of Hartford HealthCare Medical Group will provide patient registration and point-of-care services, while a Medical Group primary care provider will offer private virtual care visits, including referrals as needed. Rounding out the experience, patients will have convenient access to Walgreens pharmacy and retail services. said Jeffrey A. Flaks, President and Chief Executive Officer of Hartford HealthCare Hartford HealthCare is intent on changing the way healthcare is delivered, and this collaboration with Walgreens is another example of the variety of convenient offerings and care settings we are adding. Our organizations are working together to combine resources and best practices to create an innovative retail health environment that meets consumers' needs and exceeds their expectations. [Source:PR Newswire] "Walgreens is committed to providing patients the care they need when and how it is most convenient for them," said John Driscoll, executive vice president and president, U.S. Healthcare, Walgreens Boots Alliance. "Through this special collaboration with Hartford HealthCare, we can help keep patients more connected to high-quality care and foster long-term relationships and behaviors that help patients get and stay healthy." Together, Walgreens and Hartford HealthCare will provide one-stop convenience — a community health destination offering a health clinic, pharmacy services and retail all in one location. Patients can see their provider, pick up their medications and go shopping at their neighborhood Wcapitalalgreens. Nearly 80% of Americans live within five miles of a Walgreens store.

Read More

Healthcare Analytics

GE HealthCare Releases Sustainability Report, Shares Future Goals

GE HealthCare | September 25, 2023

First Sustainability Report since January 2023 showcases the company’s commitment to creating a world with no healthcare limits Report shows reduced operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 Strong leadership focus on sustainability efforts and ESG with a cross-functional ESP GE HealthCare has released its inaugural Sustainability Report, marking its commitment to environmental, social, and governance (ESG) practices since becoming an independent company in January 2023. The report highlights the reduction of operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 and outlines the company's dedication to ESG principles and sustainability. GE HealthCare recognizes the importance of sustainability and corporate responsibility in the healthcare industry. The report reflects the company's dedication to creating a world where healthcare knows no limits and its commitment to environmental and social impact. ESG Program Leader at GE HealthCare, Kelvin Sanborn, stated, GE HealthCare recognizes the global significance of fulfilling our purpose and delivering on our objectives and is pleased to have reduced our operational GHG emissions by 27% versus our 2019 baseline. With our broad ESG strategy and priorities in mind, we are carrying out a climate risk assessment that will inform our climate transition plan, and developing a net zero roadmap for Scope 1, 2, and 3 GHG emissions. [Source: Business Wire] Key Highlights from the Company's Inaugural Sustainability Report: Environmental Impact Since 2019, reduced GHG emissions by 27% with goals of 50% reduction by 2030 and net zero by 2050 Registered with Science Based Targets Initiative Committed to decarbonizing the healthcare sector Social Impact Established cultural operating principles Planned GE Healthcare Foundation for philanthropy Appointed chief diversity, equity, and inclusion officer Governance and Accountability Strong corporate governance as a stand-alone public company Relaunched Code of Conduct with high employee engagement Joined UN Global Compact to support sustainable development goals GE HealthCare conducted an ESG materiality assessment, defining five key focus areas for its sustainability strategy. These include expanding healthcare access, fostering diversity and inclusion, reducing greenhouse gas emissions, promoting the circular economy, and enhancing patient data cybersecurity. The report outlines the company's long-term ESG objectives and progress toward previous goals. It is preparing to release an updated task force on climate-related financial disclosures (TCFD) report once its climate risk assessment is finalized. Furthermore, the company has scheduled a materiality assessment update for 2024. In parallel, GE HealthCare is exploring the expansion of Reporting Standards for its ESG disclosures and evaluating how its objectives align with the United Nations Sustainable Development Goals (UN SDGs). After conducting an ESG materiality assessment before its spin-off, the company has pinpointed five vital areas for its sustainability strategy. These priorities, underscored by the company's core innovation, product quality, and integrity principles, encompass the following: Expanding global healthcare access by ensuring underserved populations have better healthcare opportunities; promoting a culture of inclusion and diversity; mitigating its climate impact through concerted efforts; facilitating equipment and prioritizing patient data security and cybersecurity by adhering to standardized data privacy and security practices based on global regulations such as the EU GDPR.

Read More

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Read More

More featured news